Strongbridge Biopharma PLC EBITDA Margin 2016-2021 | SBBP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Strongbridge Biopharma PLC (SBBP) over the last 10 years. The current EBITDA margin for Strongbridge Biopharma PLC as of June 30, 2021 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-06-30 | $0.03B | $-0.04B | -111.76% |
| 2021-03-31 | $0.03B | $-0.03B | -106.25% |
| 2020-12-31 | $0.03B | $-0.04B | -119.35% |
| 2020-09-30 | $0.03B | $-0.04B | -148.28% |
| 2020-06-30 | $0.03B | $-0.05B | -188.89% |
| 2020-03-31 | $0.03B | $-0.06B | -232.00% |
| 2019-12-31 | $0.02B | $-0.06B | -281.82% |
| 2019-09-30 | $0.02B | $-0.07B | -323.81% |
| 2019-06-30 | $0.02B | $-0.08B | -375.00% |
| 2019-03-31 | $0.02B | $-0.08B | -427.78% |
| 2018-12-31 | $0.02B | $-0.08B | -416.67% |
| 2018-09-30 | $0.02B | $-0.07B | -418.75% |
| 2018-06-30 | $0.01B | $-0.08B | -542.86% |
| 2018-03-31 | $0.01B | $-0.07B | -600.00% |
